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Selecting only two activity levels is difficult because EMG levels continue to change over the 1 3 5 course of the stance phase, with or without an exoskeleton (Jackson and Collins, 2015) . The 1 3 6 average SOL EMG activity level over a whole stride is ~32% of the peak activity over a whole 1 3 7 stride without the exoskeleton (see Extended Data Fig. 4; Collins et al., 2015) . We normalized al., 2010), where peak SOL EMG over a whole stride was ~95% MVC, which resulted in ~30.4% 1 4 0 MVC. When using an exoskeleton, Collins et al. (Collins et al., 2015) reported an average 1 4 1 reduction of ~22% during early-to mid-stance (0% -40% of the whole stride). However, based 1 4 2 on data from (Extended Data Fig. 4; Collins et al., 2015) , this average reduction from heel-strike 1 4 3 to mid-stance still underestimates the more typical reduction during mid-stance (ranging from 1 4 4 ~25 -29% reduction) because early-stance produces little to no EMG reduction. Thus, we 1 4 5 selected a more typical reduction level observed during mid-stance. Taking the above 1 4 6 considerations into account, controlled activity levels were set at 30% and 22% MVC of the 1 4 7 peak-to-peak SOL EMG RMS amplitude during MVC (26.7% EMG reduction). EMG level 1 4 8 validation is available (Suppl. Info. 1).
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Participants received real-time biofeedback of their SOL activity level via a computer 1 5 0 monitor so that target activity levels (22% and 30% MVC) could be achieved voluntarily for a 10 1 5 1 second test period, similar to experiments on the tibialis anterior (Raiteri and Hahn, 2019) . The 1 5 2 procedure required participants to match their real time SOL EMG (moving 0.25 second RMS 1 5 3 amplitude) to within ± 5% of a predefined EMG RMS amplitude (Fig. 1) . After a familiarization 1 5 4 session, subjects became consistent at matching their EMG activity to the desired level. activity levels. We measured the net ankle joint torque produced at each activity level at ankle 1 6 9 angles of -10° (plantar flexion), 0°, 5° (dorsiflexion), 10°, 15°, 20°, 25°, 30°, and 35°. Dorsiflexion > 25° ankle angle was not a dorsiflexion range all subjects could reach without 1 7 1 discomfort. Therefore, some of the extreme dorsiflexion positions were captured only for a subset 1 7 2 of participants (n = 11 at 30°, n = 10 at 35°). Passive (0% activity level) torque data was also 1 7 3 captured by moving the ankle between -10° and 35° at 1°s -1 for five full cycles and the last 2 1 7 4 rotations were averaged. The first three rotations were completed to precondition the subject to Contractions were produced from the lowest to highest activity levels and the order of angles within each activity level was randomized. This procedure was selected to minimize the 1 7 8 effects of fatigue from the MVCs. Each contraction lasted six and ten seconds for MVC and 1 7 9 submaximal activity levels, respectively. Subjects received 3-minutes rest between MVC 1 8 0 contractions, at least 30 seconds rest between submaximal activity level contractions, and 5-1 8 1 minutes rest between the activity conditions. More time was given upon request from the considering changes to passive torque caused by fascicle shortening during activation (Suppl. Active torque-ankle angle and active torque-active fascicle length relationship data were 1 9 8 calculated for each participant, normalized to maximal torque, plotted with all participants, and a 1 9 9 second-order polynomial equation was then fitted for each activity level. We used these equations 2 0 0 to estimate optimal ankle angle and fascicle length at peak plantar flexion torque for the 100% 2 0 1 activity level. angles, for each muscle, we designed a full-factorial, 2-way ANOVA with fixed effects for 2 0 5 activity level (100%, 30%, 22%) and ankle angle (-10°, 0°, 5°, 10°, 15°, 20°, 25°, 30°, and 35°), test for equality of variances. To limit data skewing, outliers (data points > 2 standard deviations 2 1 2 from the mean) were removed. A best Box-Cox transformation was used for all data sets to meet 2 1 3 assumptions. When model effects were significant, a post-hoc Tukey Honestly Significant Fascicle Length. -SOL ( Fig. 2A ; Table 1 ) and LG ( Fig. 2B ; Table 1 ) fascicle lengths showed 2 2 0 similar trends, with increasing lengths as the ankle moved to more dorsiflexed positions and 2 2 1 decreasing lengths with increasing activity levels. During fixed-end contractions, SOL fascicles 2 2 2 shortened on average 20.6%, 25.7% and 34.0% of passive length for the 22%, 30%, and 100% 2 2 3 activity levels, respectively. LG fascicles shortened on average 21.6%, 23.5%, and 28.6% of passive length for the 22%, 30%, and 100% activity levels, respectively. For both muscles, 100% 2 2 5 and 0% activity levels produced the shortest and longest fascicles, respectively (Tukey HSD, P < 2 2 6 0.05). However, only SOL fascicle lengths significantly decreased from 22% to 30% activity 2 2 7 (Tukey HSD, P < 0.05). However, on visual inspection of LG data from each participant, a 2 2 8 consistent decrease in fascicle length was present from the 30% to 22% activity levels at all 2 2 9 angles. activity levels at all ankle angles (Tukey HSD, P < 0.05; Fig. 3 ; Table 2 ). At maximum torque, 2 3 2 22% and 30% activity levels produced ~48% and ~56% of the 100% MVC torque, respectively. 100% torque (at a given angle) as the ankle became more plantar flexed ( Fig. 3 ; Table 2 ). The 2 3 5 100% activity level produced a typical torque-angle relationship, with a long ascending limb and 2 3 6 peak active torque being produced at an estimated optimal angle of ~25° (Fig 3, vertical line) . The statistical analysis indicates that values between 20° and 30° ankle angle were not different presumably exist at ankle levels not physiologically possible > 35° with an extended knee. achieved an ascending limb, a plateau region with an optimal fascicle length at ~25°, and (albeit 2 7 5 short) a descending limb. In contrast, SOL and LG fascicles only produced an ascending limb and 2 7 6 plateau region at the SOL-matched 22% and 30% activity levels. The ascending limb of the 2 7 7 torque-fascicle length curve was shifted towards longer lengths for the 22% compared to the 30% 2 7 8 activity levels. This shift was greater at more plantar flexed angles; for example, at an ankle angle 2 7 9 of -10°, SOL fascicle length was shifted to ~20% longer fascicle lengths at 22% compared to 2 8 0 30% activity. Similar to the torque-ankle angle relationship, the torque-fascicle length 2 8 1 relationship can be assumed to have a descending limb at ankle angles >35°, which for our 2 8 2 participants were not physiologically possible with an extended knee. Although we cannot precisely locate the optimal fascicle lengths, based on the graphs, we 2 8 4 can see that the SOL and LG exhibit activation-dependence of optimal fascicle length; decreasing 2 8 5 activity level increased SOL and LG fascicle lengths. The underlying mechanism to explain this 2 8 6 phenomenon is a current hot topic of research (Holt and Williams, 2018; MacIntosh, 2017) . Activation-dependence of optimal length, often called length-dependent activation, is an umbrella 2 8 8 term that covers subcellular and MTU level mechanisms that are not necessarily mutually 1998). The exact molecular mechanism for this property is not yet clear, but seems to be shift in optimal triceps surae MTU length caused primarily by MTU compliance. During 3 0 0 contraction, muscle fascicles produce force and as activation increases, the muscle fascicles 3 0 1 shorten further, subsequently increasing the strain of the in-series Achilles tendon. Thus, the 3 0 2 amount of Achilles tendon strain for a given joint configuration is related to the amount of 3 0 3 muscle activity (and muscle force). The overall result is that reduced activity levels lead to a shift 3 0 4 in the optimal ankle angle and optimal fascicle length towards more dorsiflexed ankle angles (and 3 0 5 MTU lengths) and longer fascicle lengths, respectively. induced fascicle shortening, so we would also predict residual force depression to arise during the 3 1 5 substantial fascicle shortening observed in the SOL and LG (>20% shortening from 0% to 30% 3 1 6 activity). Although we assume that residual force depression is less for the 22% compared with Are the changes to torque-fascicle length curves between 30% and 22% activity levels during the stance phase of walking onto our torque-fascicle length figures for SOL (Fig. 4A,   3 2 3 arrows;
LG data was not readily available). For unassisted walking, we combined ultrasound- suggesting that they are coupled. Finally, the ascending limb during 22% MVC is steeper than 3 3 0 that during 30% MVC, which suggests that during the crucial powered plantarflexion of stance, An activation-dependent change in torque-fascicle length properties also means that the 3 3 4 underlying sarcomeres are likely changed by a similar amount, which could have further 3 3 5 consequences for force production. This data can be extrapolated to estimate the sarcomere 3 3 6 lengths of SOL and LG at fascicle lengths and activity levels typical during stance. Previous LG and MG sarcomere lengths are < 2.1 µm (Maganaris, 2004) , much shorter than that required for maximal overlap and force production (~2.7 µm in humans (Gollapudi and Lin, 2009)). If we 3 4 0 assumed a linear increase in sarcomere length to fascicle length, then based on our data, the 3 4 1 operating sarcomere length becomes longer along with fascicle length at 30%, and even longer at 3 4 2 the 22% activity level. This has the potential to move the sarcomeres to more favorable filament 3 4 3 overlap for force production. However, it is important to consider that measuring sarcomere 3 4 4 length in vivo during voluntary contractions still remains a difficult task. Technology to image 3 4 5 and measure sarcomere lengths during in vivo muscle contraction is advancing rapidly 3 4 6 (Lichtwark et al., 2018; Sanchez et al., 2015) and so direct measurements of SOL and LG 3 4 7 sarcomere lengths during walking will hopefully be possible to confirm our estimates in the Although the activity-dependent changes to torque-fascicle length properties seem 3 5 0 relatively substantial, it is important to note that the simulated decrease in muscle activity used 3 5 1 here was derived from data where the ankle exoskeleton stiffness was set at a level that 3 5 2 minimized metabolic cost for the user (Collins et al., 2015) . Thus, there are cost-benefit tradeoffs. The benefits of reduced muscle activity are most obviously the reduction in the metabolic cost torque-fascicle length curves also produce consequences for SOL and LG force production. However, the associated costs of operating at different fascicle lengths at the activity levels we 3 6 1 selected were outweighed by the benefits of reduced muscle activation. In the future, it would be 3 6 2 interesting to reduce muscle activity further and quantify the torque-fascicle length cost-benefit 3 6 3
properties. is the relationship between series ankle elasticity and minimizing opposite limb heel collision 3 6 6 (Ruina et al., 2005; Zelik et al., 2014) . Significant forward energy gained by powered 3 6 7 plantarflexion can be lost during heel collision of the opposite limb, requiring an increase of 3 6 8 positive work from muscles for the walker to maintain speed (increasing metabolic costs). Collision losses are minimized by a well-timed push-off of the trailing limb just before collision 3 7 0 of the leading leg, which leads to the heel driving into the ground at an angle that is modeled to walking speed (and presumably an increase in muscle activity), optimal series elastic stiffness 3 7 6 remains relatively constant among walking speeds (Zelik et al., 2014) . In our data, SOL fascicle 3 7 7 lengths at 22% vs. 30% muscle activities were longer, indicating that the Achilles tendon was 3 7 8 stretched less, which may result in a more compliant MTU, considering that force is low and the 3 7 9 tendon may still operate in its toe region. Thus, it is possible that wearing a lower limb assistive 3 8 0 device that reduces muscle activity has the potential to decrease in series elastic stiffness, and 3 8 1 ultimately lead to an increase in collision force and the metabolic cost of transport. The , 2012; Houdijk et al., 2009 ) and need to be conducted in exoskeletons. We predict 3 8 6 that the decrease in activity level associated with wearing lower limb assistive devices has the 3 8 7 potential to increase collision-based forces and thereby increase the metabolic cost of walking. Theor. Biol. 252, 662-673. Lloyd, D. G. and Besier, T. F. (2003) . An EMG-driven musculoskeletal model to estimate 5 1 0 muscle forces and knee joint moments in vivo. J. Biomech. 36, 765-776. Maganaris, C. N., Baltzopoulos, V. and Sargeant, A. J. (1998) . Changes in Achilles tendon 5 2 1 moment arm from rest to maximum isometric plantarflexion: in vivo observations in man. 
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